Cue Biopharma, Inc. · NASDAQ:CUE
Mark E. Strome's stake in Cue Biopharma, Inc. fell to 8.50% (Schedule 13G/A)
Event Jul 14, 2026 · Filed Oct 8, 2026
Mark E. Strome's stake in Cue Biopharma, Inc. fell to 8.50%, 644,916 shares, as a passive investor on Jul 14, 2026. Filed Oct 8, 2026 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 644,916
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mark E. Strome | 8.50% | 644,916 |
| Strome Group, Inc. | 8.48% | 643,242 |
| Strome Investment Management, LP | 8.48% | 643,242 |
| Strome Dynasty, LLC | 0.66% | 50,000 |
| Strome Mezzanine Fund, LP | 0% | 0 |
| Strome Mezzanine Fund II, LP | 7.82% | 593,242 |